Results From The 2021 CISCRP Perceptions & Insights Study Coming Soon

By: Jessica Cronin 

CISCRP is excited to announce that the full results of the 2021 global Perceptions & Insights Study will be available this fall! This latest study contains insights from nearly 12,000 individuals around the world on various aspects of clinical research — including the impact of the COVID-19 pandemic on awareness and perceptions, as well as thoughts on and experiences with clinical trials that require fewer visits (decentralized trials). These results uncover significant new findings on patient engagement preferences and ways to increase access, particularly among underrepresented communities.

Our 2021 study captured the experiences of over 5,500 trial participants across diverse therapeutic areas, which was nearly 2,000 more participants than in previous years!

Key findings from the 2021 Perceptions & Insights Study include:

• Most respondents (75%) noted that the COVID-19 pandemic increased their overall awareness of clinical research, particularly among those from ethnically and racially underrepresented communities.
• Individuals from ethnically and racially underrepresented communities were significantly more likely to cite that knowing pharmaceutical companies employed diverse staff would help to increase their trust in pharmaceutical companies.
• While most (82%) said that they were willing to participate in clinical research, about one third of individuals (36%) cited being more willing to participate as a result of the COVID-19 pandemic.
• Of those who participated in a clinical trial during the pandemic, top changes reported included a shift from in-person visits to virtual clinic visits (over the telephone or computer), and an increase in the use of telemedicine and home trial drug delivery. Only 20% reported that their clinical trial was temporarily stopped. Consistent with prior studies, most clinical trial participants (92%) noted that their trial met or exceeded their expectations, with a significant percentage (95%) willing to participate in another trial in the future — a strong indicator of overall satisfaction.

Since 2013, CISCRP has conducted the Perceptions & Insights Study every other year to monitor trends and identify opportunities to better inform and engage the public and patients as partners in the clinical research enterprise.

To review these findings and more from the 2021 Perceptions & Insights Study, CISCRP will be hosting a webinar in October, as well as posting reports on the CISCRP website. If you would like to register for the webinar – please go to here.